| Cancer-related molecular mechanisms research | Lifetime | 26 | CN 9 | 99.77 |
| Circular RNAs in diseases | Lifetime | 13 | CN 5 | 99.79 |
| MicroRNA in disease regulation | Lifetime | 28 | CN 6 | 99.79 |
| RNA modifications and cancer | Lifetime | 140 | CN 8 | 99.57 |
| Extracellular vesicles in disease | Lifetime | 189 | CN 53 | 98.09 |
| Lung Cancer Treatments and Mutations | Lifetime | 684 | CN 40 | 98.56 |
| Pharmacological Effects of Natural Compounds | Lifetime | 538 | CN 152 | 96.58 |
| Traditional Chinese Medicine Analysis | Lifetime | 229 | CN 182 | 96.59 |
| Ferroptosis and cancer prognosis | Lifetime | 527 | CN 285 | 94.73 |
| Molecular Biology Techniques and Applications | Lifetime | 708 | CN 29 | 95.45 |
| Ginseng Biological Effects and Applications | Lifetime | 249 | CN 126 | 95.89 |
| Cancer Mechanisms and Therapy | Lifetime | 496 | CN 80 | 95.21 |
| Advanced Proteomics Techniques and Applications | Lifetime | 481 | CN 32 | 95.54 |
| Acupuncture Treatment Research Studies | Lifetime | 525 | CN 183 | 93.10 |
| Traditional Chinese Medicine Studies | Lifetime | 619 | CN 357 | 89.91 |
| Advanced Biosensing Techniques and Applications | Lifetime | 839 | CN 167 | 91.52 |
| Flavonoids in Medical Research | Lifetime | 759 | CN 325 | 77.17 |
| Andrographolide Research and Applications | Lifetime | 683 | CN 182 | 47.79 |
| MicroRNA in disease regulation | 2021-2025 | 11 | CN 7 | 99.74 |
| Cancer-related molecular mechanisms research | 2021-2025 | 49 | CN 33 | 99.54 |
| Circular RNAs in diseases | 2021-2025 | 39 | CN 28 | 98.89 |
| RNA modifications and cancer | 2021-2025 | 190 | CN 129 | 98.14 |
| Extracellular vesicles in disease | 2021-2025 | 93 | CN 58 | 97.80 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 36 | CN 6 | 95.93 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 61 | CN 15 | 95.52 |
| Epigenetics and DNA Methylation | 2021-2025 | 292 | CN 109 | 95.25 |
| RNA Interference and Gene Delivery | 2021-2025 | 179 | CN 95 | 96.71 |
| Cancer Genomics and Diagnostics | 2021-2025 | 653 | CN 46 | 95.99 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 243 | CN 98 | 95.77 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 691 | CN 139 | 95.80 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 76 | CN 11 | 90.41 |
| Ferroptosis and cancer prognosis | 2021-2025 | 647 | CN 550 | 92.27 |
| Cancer Mechanisms and Therapy | 2021-2025 | 161 | CN 62 | 90.60 |
| Cancer Cells and Metastasis | 2021-2025 | 620 | CN 128 | 87.25 |
| Curcumin's Biomedical Applications | 2021-2025 | 261 | CN 35 | 79.36 |
| Glutathione Transferases and Polymorphisms | 2021-2025 | 74 | CN 11 | 77.63 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 391 | CN 65 | 74.86 |
| Flavonoids in Medical Research | 2021-2025 | 133 | CN 43 | 69.97 |
| Parasitic infections in humans and animals | 2021-2025 | 596 | CN 146 | 64.68 |
| Medicinal plant effects and applications | 2021-2025 | 301 | CN 100 | 54.63 |
| Berberine and alkaloids research | 2021-2025 | 693 | CN 382 | 42.04 |
